Selected article for: "disease outbreak and human infection"
Author: Michael Jay Corley; Christopher Sugai; Michael Schotsaert; Robert E. Schwartz; Lishomwa C Ndhlovu
Title: Comparative in vitro transcriptomic analyses of COVID-19 candidate therapy hydroxychloroquine suggest limited immunomodulatory evidence of SARS-CoV-2 host response genes.
  • Document date: 2020_4_14
    • ID: 30x26ip7_1
    Snippet: An outbreak of a novel respiratory disease appeared in Wuhan, China in December 2019 [1] capable of human infection and stealth transmission [2, 3] . Rapid scientific investigation identified the causative pathogen as a coronavirus named SARS-CoV-2 with similarity to SARS. Clinical observations have shown that the disease arising from SARS-CoV-2 infection termed COVID-19 is characterized by a myriad of symptoms including cough, fever, lethargy, a.....
    Document: An outbreak of a novel respiratory disease appeared in Wuhan, China in December 2019 [1] capable of human infection and stealth transmission [2, 3] . Rapid scientific investigation identified the causative pathogen as a coronavirus named SARS-CoV-2 with similarity to SARS. Clinical observations have shown that the disease arising from SARS-CoV-2 infection termed COVID-19 is characterized by a myriad of symptoms including cough, fever, lethargy, and difficulty breathing [3] . Currently, there remains no effective therapy for COVID-19; hence, a variety of clinical trials are under way to identify an effective COVID-19 therapy.

    Search related documents:
    Co phrase search for related documents
    • causative pathogen and effective therapy: 1, 2, 3, 4
    • causative pathogen and human infection: 1, 2, 3
    • causative pathogen and novel respiratory disease: 1, 2
    • causative pathogen and novel respiratory disease outbreak: 1
    • causative pathogen and respiratory disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • causative pathogen and SARS infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • causative pathogen identify and effective therapy: 1, 2
    • causative pathogen identify and respiratory disease: 1
    • China Wuhan appear and SARS infection: 1
    • clinical observation and effective therapy: 1
    • clinical observation and human infection: 1
    • clinical observation and novel respiratory disease: 1
    • clinical observation and respiratory disease: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • clinical observation and SARS infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • clinical trial and effective therapy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • clinical trial and effective therapy identify: 1, 2
    • clinical trial and human infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • clinical trial and novel respiratory disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • clinical trial and SARS infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25